Contineum Therapeutics
Jules Lee is currently serving as the Senior Director of Clinical Operations at Contineum Therapeutics since June 2021. Prior to this role, Jules held the position of Director of Clinical Operations at Cirius Therapeutics from June 2017 to October 2020. With a background in clinical project management and program management, Jules has also worked at companies such as Medivation, FibroGen, Boehringer Ingelheim, and Quintiles. Jules holds a Master of Public Health and Community Medicine from the University of Sydney, as well as a Bachelor of Medical Science with a focus on Immunology and Biochemistry from the same institution.
Contineum Therapeutics
Contineum Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need. Contineum targets biological pathways associated with specific clinical disabilities, that once modulated, can demonstrably impact the course of disease.